Compare VITL & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VITL | RLMD |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 557.9M | 461.9M |
| IPO Year | 2020 | 2012 |
| Metric | VITL | RLMD |
|---|---|---|
| Price | $9.42 | $3.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $13.22 | $10.75 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 11-03-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 22.03 | ★ 45.28 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $759,444,000.00 | $13,070.00 |
| Revenue This Year | $1.33 | N/A |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 25.26 | ★ 154.83 |
| 52 Week Low | $7.95 | $1.80 |
| 52 Week High | $43.80 | $8.00 |
| Indicator | VITL | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.21 | 33.22 |
| Support Level | $8.73 | $3.22 |
| Resistance Level | $13.71 | $4.44 |
| Average True Range (ATR) | 0.53 | 0.20 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 17.69 | 26.07 |
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.